Genentech Pulmozyme
Executive Summary
Firm recalls one lot (500 cartons) of dornase alfa cystic fibrosis therapy after finding small punctures in some of the ampules upon shipping. Company recalled 23 lots of the drug a year ago due to similar ampule leakage problems, citing packaging defects. Genentech recalled a Pulmozyme lot in February in conjunction with the reorganization of its South San Francisco manufacturing facility following a warning letter (1"The Pink Sheet" Jan. 1, p. 28)